Cargando…

Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing

SIMPLE SUMMARY: Accurate diagnosis of sarcoma can be difficult as there are over 100 different subtypes. Approximately one third of sarcomas are characterised by subtype-specific genetic variants, which are routinely detected by the molecular testing of tumour biopsies. Recent studies have shown the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mc Connell, Lauren, Gazdova, Jana, Beck, Katja, Srivastava, Shambhavi, Harewood, Louise, Stewart, JP, Hübschmann, Daniel, Stenzinger, Albrecht, Glimm, Hanno, Heilig, Christoph E., Fröhling, Stefan, Gonzalez, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761870/ https://www.ncbi.nlm.nih.gov/pubmed/33287361 http://dx.doi.org/10.3390/cancers12123627

Ejemplares similares

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
por: Horak, Peter, et al.
Publicado: (2016)

Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
por: Simon, Malte, et al.
Publicado: (2021)

Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
por: Simon, Malte, et al.
Publicado: (2022)

Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019)

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
por: Jaramillo, Sonia, et al.
Publicado: (2020)

Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling
por: Teleanu, Maria‐Veronica, et al.
Publicado: (2023)

The landscape of chromothripsis across adult cancer types
por: Voronina, Natalia, et al.
Publicado: (2020)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
por: Gröschel, Stefan, et al.
Publicado: (2016)

Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance
por: Horak, Peter, et al.
Publicado: (2019)

Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature
por: Koelsche, Christian, et al.
Publicado: (2021)

Successful BRAF/MEK inhibition in a patient with BRAF(V600E)-mutated extrapancreatic acinar cell carcinoma
por: Busch, Elena, et al.
Publicado: (2020)

A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
por: McCafferty, Neil, et al.
Publicado: (2022)

Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2020)

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
por: Rieke, Damian T., et al.
Publicado: (2022)

Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Lenschow, Christina, et al.
Publicado: (2021)

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology
por: Mock, Andreas, et al.
Publicado: (2023)

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity
por: Möhrmann, Lino, et al.
Publicado: (2022)

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards
por: Perera-Bel, Júlia, et al.
Publicado: (2018)

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
por: Heilig, C.E., et al.
Publicado: (2021)

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
por: Gröschel, Stefan, et al.
Publicado: (2019)

RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
por: Mechtersheimer, Gunhild, et al.
Publicado: (2021)

Circulation in Fibro-Sarcomas
por: Kini, M. G.
Publicado: (1942)

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
por: Rempel, E., et al.
Publicado: (2022)

Next-generation sequencing: hype and hope for development of personalized radiation therapy?
por: Tinhofer, Ingeborg, et al.
Publicado: (2015)

Integrative genomic and transcriptomic analysis of leiomyosarcoma
por: Chudasama, Priya, et al.
Publicado: (2018)

Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)
por: Menzel, Michael, et al.
Publicado: (2023)

Pediatric Sarcomas: The Next Generation of Molecular Studies
por: Giannikopoulos, Petros, et al.
Publicado: (2022)

Colorectal cancer‐initiating cells caught in the act
por: Dieter, Sebastian M, et al.
Publicado: (2017)

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2020)

Phylogenetic analysis of swine & human hepatitis E virus
por: Sarangi, Aditya Narayan, et al.
Publicado: (2011)

Sarcoma classification by DNA methylation profiling
por: Koelsche, Christian, et al.
Publicado: (2021)

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
por: Azoitei, Ninel, et al.
Publicado: (2012)

MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
por: Niger, Monica, et al.
Publicado: (2022)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Accurate and efficient detection of gene fusions from RNA sequencing data
por: Uhrig, Sebastian, et al.
Publicado: (2021)

Retroviral Vectors: Post Entry Events and Genomic Alterations
por: Nowrouzi, Ali, et al.
Publicado: (2011)

Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia
por: Horak, Peter, et al.
Publicado: (2020)

Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia
por: Horak, Peter, et al.
Publicado: (2021)

Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?
por: Wagner, Lars M.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ovg8rjb42sj31up2pjfc6n7k0k